Infectious Medicine2025，Vol.4Issue(1)：P.88-93,6.DOI:10.1016/j.imj.2025.100166
Personalized immunization against Mpox Clades I and Ib:Strategies to combat the emerging epidemic
Deepak Kumar 1Rishabha Malviya 2Shriyansh Srivastava 1Sathvik Belagodu Sridhar 3Sirajunisa Talath 3Javedh Shareef 3Bhupendra G.Prajapati4
作者信息
- 1. Department of Pharmacy,School of Medical and Allied Sciences,Galgotias University,Greater Noida 203201,India
- 2. Department of Pharmacy,School of Medical and Allied Sciences,Galgotias University,Greater Noida 203201,India Galgotias Multi-Disciplinary Research&Development Cell(G-MRDC),Galgotias University,Greater Noida 201308,U.P.,India
- 3. RAK College of Pharmacy,RAK Medical&Health Sciences University,Ras al Khaimah 11172,United Arab Emirates
- 4. Department of Pharmaceutics,Shree S.K.Patel College of Pharmaceutical Education and Research,Ganpat University,Mehsana 384012,India Faculty of Pharmacy,Silpakorn University,Nakhon Pathom 73000,Thailand
- 折叠
摘要
关键词
Orthopoxvirus/Clade Ib/MVA-BN/LC16-KMB/OrthopoxVac/Global outbreak分类
医药卫生引用本文复制引用
Deepak Kumar,Rishabha Malviya,Shriyansh Srivastava,Sathvik Belagodu Sridhar,Sirajunisa Talath,Javedh Shareef,Bhupendra G.Prajapati..Personalized immunization against Mpox Clades I and Ib:Strategies to combat the emerging epidemic[J].Infectious Medicine,2025,4(1):P.88-93,6.
